APR - APR STOCK NEWS

Apria announced the successful completion of a secondary offering of 5,175,000 shares of its common stock at a price of $27.00 per share, generating over $139.7 million in gross proceeds. The offering involved shares sold by a stockholder affiliated with Blackstone, with no shares offered by Apria itself. The company did not receive any net proceeds from this transaction. Major banks such as Citigroup and Goldman Sachs led the offering, contributing to market liquidity and investor interest.

Apria, Inc. (Nasdaq: APR) announced the pricing of a secondary offering of 4,500,000 shares at $27.00 each, initiated by a selling stockholder associated with Blackstone. An additional 675,000 shares may be purchased by underwriters within 30 days. The offering will close on June 14, 2021, pending standard conditions. Apria will not receive any proceeds from this sale. The offering is managed by Citigroup and Goldman Sachs, with other banks assisting in the process. Apria remains focused on providing home healthcare services.

On June 07, 2021, Apria announced a secondary offering of 4,500,000 shares of common stock by a selling stockholder affiliated with Blackstone. The offering includes a 30-day option for underwriters to purchase an additional 675,000 shares. Apria will not sell any shares or receive proceeds from this offering. Citigroup and Goldman Sachs are the lead managers, with BofA Securities, UBS, and J.P. Morgan as joint managers. The offering is subject to SEC regulations, and a preliminary prospectus will be available from the managing underwriters.

Apria (Nasdaq: APR), a prominent U.S. provider of home healthcare equipment, will participate in two significant healthcare conferences. CEO Dan Starck and CFO Debby Morris will speak at the UBS Global Healthcare Virtual Conference on May 26, 2021, at 10:00 a.m. (ET) and at the Goldman Sachs 42^nd Annual Global Healthcare Conference on June 8, 2021, at 11:20 a.m. (ET). Webcast links and presentation materials will be available on Apria's investor relations website.

Apria has appointed Susannah Gray and Terri Kline to its Board of Directors, enhancing its leadership with extensive healthcare experience. Gray has held executive roles in finance at Royalty Pharma and various board positions, while Kline has strong advisory expertise in healthcare, including executive positions at Henry Ford Health System. CEO Dan Starck emphasized that their addition will support Apria's growth and commitment to improving patient care at home.

Apria, Inc. (Nasdaq: APR) reported Q1 2021 results with net revenue of $275.3 million, a 2% increase from $269.2 million in Q1 2020. However, net income fell 29% to $4.5 million from $6.4 million. Adjusted EBITDA rose 15% to $48.3 million. For Q2 2021, the company expects net revenue between $277 million and $283 million, and adjusted EBITDA of $51 million to $55 million. Full-year guidance was raised, projecting net revenue of $1.12 billion to $1.14 billion and adjusted EBITDA of $207 million to $216 million.

Apria, Inc. (Nasdaq: APR) announced the release date for its fiscal Q1 2021 financial results, set for May 13, 2021, after market close. The company will host a conference call at 5:00 p.m. ET to discuss these results. The conference call can be accessed by U.S. participants at (833) 362-0207 and international participants at (914) 987-7676, using conference ID # 5247226. Apria provides integrated home healthcare services across 275 locations, serving approximately 2 million patients annually.

Apria, Inc. (Nasdaq: APR) reported robust financial results for Q4 and full year 2020, showcasing a 5% increase in net revenue to $293.8 million and a 347% surge in net income to $25.9 million. For the entire year, net revenue rose 2% to $1.11 billion with net income soaring 195% to $46.1 million. The company credits operational efficiencies and increased demand for oxygen therapy amid the pandemic. Looking ahead, Apria projects 2021 net revenue between $1.11 billion and $1.14 billion, with adjusted EBITDA ranging from $203 million to $212 million.

Apria, Inc. (Nasdaq: APR) announced it will release its fiscal fourth quarter and full-year financial results on March 30, 2021, after market close. The company will hold a conference call at 5:00 p.m. ET to discuss these results. Participants can join the call via a designated phone number or through a live audio webcast. Apria, a leading provider of home healthcare equipment, operates approximately 275 locations and serves nearly 2 million patients annually in the U.S. All locations are accredited by The Joint Commission.